Karl S.  Dahlquist net worth and biography

Karl Dahlquist Biography and Net Worth

Chief Legal Officer of AtriCure

Karl S. Dahlquist, J.D., C.C.E.P. has served as our Chief Legal Officer since March 2019. Mr. Dahlquist joined the Company in August 2013 as Vice President, Legal and Regulatory Affairs and Chief Compliance Officer. Mr. Dahlquist began his career as a lawyer specializing in medical device litigation and regulation at an international law firm. In 1999, he left private practice to join the legal department of Medtronic, Inc., where he was Senior Counsel to the Spinal & Biologics business. Mr. Dahlquist subsequently served in a variety of senior legal, compliance and quality management roles with St. Jude Medical, GE Healthcare and Johnson & Johnson. He attended the University of Michigan in Ann Arbor, where he earned Bachelor of Science and Juris Doctor degrees.

What is Karl S. Dahlquist's net worth?

The estimated net worth of Karl S. Dahlquist is at least $1.63 million as of March 18th, 2024. Mr. Dahlquist owns 50,954 shares of AtriCure stock worth more than $1,628,999 as of April 22nd. This net worth estimate does not reflect any other assets that Mr. Dahlquist may own. Additionally, Mr. Dahlquist receives an annual salary of $762,390.00 as Chief Legal Officer at AtriCure. Learn More about Karl S. Dahlquist's net worth.

How old is Karl S. Dahlquist?

Mr. Dahlquist is currently 53 years old. There are 6 older executives and no younger executives at AtriCure. The oldest executive at AtriCure is Mr. Douglas J. Seith, Chief Operating Officer, who is 58 years old. Learn More on Karl S. Dahlquist's age.

What is Karl S. Dahlquist's salary?

As the Chief Legal Officer of AtriCure, Inc., Mr. Dahlquist earns $762,390.00 per year. There are 4 executives that earn more than Mr. Dahlquist. The highest earning executive at AtriCure is Mr. Michael H. Carrel, CEO, President & Director, who commands a salary of $2,010,000.00 per year. Learn More on Karl S. Dahlquist's salary.

How do I contact Karl S. Dahlquist?

The corporate mailing address for Mr. Dahlquist and other AtriCure executives is 7555 INNOVATION WAY, MASON OH, 45040. AtriCure can also be reached via phone at (513) 755-4100 and via email at lynn@gilmartinir.com. Learn More on Karl S. Dahlquist's contact information.

Has Karl S. Dahlquist been buying or selling shares of AtriCure?

Karl S. Dahlquist has not been actively trading shares of AtriCure during the past quarter. Most recently, Karl S. Dahlquist sold 1,885 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $32.16, for a transaction totalling $60,621.60. Following the completion of the sale, the insider now directly owns 50,954 shares of the company's stock, valued at $1,638,680.64. Learn More on Karl S. Dahlquist's trading history.

Who are AtriCure's active insiders?

AtriCure's insider roster includes Tonya Austin (Insider), Mark Collar (Director), Karl Dahlquist (Chief Legal Officer), Vinayak Doraiswamy (Insider), Scott Drake (Director), Regina Groves (Director), David Grumhaus, Jr. (Portfolio Manager), Justin Noznesky (Insider), Karen Prange (Director), Salvatore Privitera (Insider), Douglas Seith (COO), Sven Wehrwein (Director), Angela Wirick (CFO), and Maggie Yuen (Director). Learn More on AtriCure's active insiders.

Are insiders buying or selling shares of AtriCure?

During the last year, AtriCure insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $111,250.00. During the last year, insiders at the medical device company sold shares 3 times. They sold a total of 11,100 shares worth more than $352,912.00. The most recent insider tranaction occured on March, 5th when Director Karen Prange sold 6,100 shares worth more than $232,532.00. Insiders at AtriCure own 3.2% of the company. Learn More about insider trades at AtriCure.

Information on this page was last updated on 3/5/2025.

Karl S. Dahlquist Insider Trading History at AtriCure

See Full Table

Karl S. Dahlquist Buying and Selling Activity at AtriCure

This chart shows Karl S Dahlquist's buying and selling at AtriCure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$200k$0$200kTotal Insider BuyingTotal Insider Selling

AtriCure Company Overview

AtriCure logo
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Read More

Today's Range

Now: $31.97
Low: $31.55
High: $32.43

50 Day Range

MA: $34.88
Low: $30.61
High: $40.94

2 Week Range

Now: $31.97
Low: $18.94
High: $43.11

Volume

624,592 shs

Average Volume

655,722 shs

Market Capitalization

$1.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.65